Cite
Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs.
MLA
Wu, Lige, et al. “Progression Patterns, Resistant Mechanisms and Subsequent Therapy for ALK-Positive NSCLC in the Era of Second-Generation ALK-TKIs.” Journal of Translational Medicine, vol. 22, no. 1, June 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12967-024-05388-0.
APA
Wu, L., Zou, Z., Li, Y., Hao, X., Ying, J., Li, J., & Xing, P. (2024). Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs. Journal of Translational Medicine, 22(1), 1–13. https://doi.org/10.1186/s12967-024-05388-0
Chicago
Wu, Lige, Zihua Zou, Yan Li, Xuezhi Hao, Jianming Ying, Junling Li, and Puyuan Xing. 2024. “Progression Patterns, Resistant Mechanisms and Subsequent Therapy for ALK-Positive NSCLC in the Era of Second-Generation ALK-TKIs.” Journal of Translational Medicine 22 (1): 1–13. doi:10.1186/s12967-024-05388-0.